The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Betta Pharmaceuticals
Leadership - Betta Pharmaceuticals
Stock and Other Ownership Interests - Betta Pharmaceuticals
Different exposure duration of adjuvant icotinib in stage II-IIIA non-small cell lung cancer patients with positive EGFR mutation (ICOMPARE study): A randomized, open-label phase 2 study.
 
Chao Lyu
No Relationships to Disclose
 
Rui Wang
No Relationships to Disclose
 
Shaolei Li
No Relationships to Disclose
 
Shi Yan
No Relationships to Disclose
 
Yuzhao Wang
No Relationships to Disclose
 
Jinfeng Chen
No Relationships to Disclose
 
Liang Wang
No Relationships to Disclose
 
Yinan Liu
No Relationships to Disclose
 
Zhanlin Guo
No Relationships to Disclose
 
Jia Wang
No Relationships to Disclose
 
Yuquan Pei
No Relationships to Disclose
 
Lei Yu
No Relationships to Disclose
 
Nan Wu
No Relationships to Disclose
 
Jun Chen
No Relationships to Disclose
 
Yanheng Liu
No Relationships to Disclose
 
Shanqing Li
No Relationships to Disclose
 
Bing Han
No Relationships to Disclose
 
Lieming Ding
Employment - Betta Pharmaceuticals
Leadership - Betta Pharmaceuticals
Stock and Other Ownership Interests - Betta Pharmaceuticals
 
Li Mao
No Relationships to Disclose
 
Yue Yang
No Relationships to Disclose